Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
ANI Pharmaceuticals, Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
ANIP
Nasdaq
2834
www.anipharmaceuticals.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for ANI Pharmaceuticals, Inc.
Is ANI Pharmaceuticals (ANIP) Pricing Reflect Long Term Value After Strong Multi Year Returns
- Feb 7th, 2026 7:03 am
Is ANI Pharmaceuticals (ANIP) a Great Value Stock Right Now?
- Feb 6th, 2026 7:40 am
3 Small-Cap Stocks That Fall Short
- Feb 3rd, 2026 9:31 pm
Are Medical Stocks Lagging Aldeyra Therapeutics (ALDX) This Year?
- Feb 3rd, 2026 7:40 am
Implied Volatility Surging for ANI Pharmaceuticals Stock Options
- Jan 27th, 2026 6:51 am
1 Cash-Producing Stock on Our Buy List and 2 We Brush Off
- Jan 25th, 2026 9:37 pm
Assessing ANI Pharmaceuticals (ANIP) Valuation After Mixed Share Performance And Cortrophin Gel Growth Prospects
- Jan 24th, 2026 12:07 pm
3 Value Stocks with Questionable Fundamentals
- Jan 20th, 2026 9:30 pm
Is ANI Pharmaceuticals (ANIP) Stock Outpacing Its Medical Peers This Year?
- Jan 16th, 2026 7:40 am
ANIP vs. TEVA: Which Drug Stock Is the Better Buy Right Now?
- Jan 16th, 2026 6:52 am
ANIP Stock Rises 7% in a Week: Here's What You Should Know
- Jan 15th, 2026 6:32 am
ANI Pharmaceuticals (ANIP) Is Up 7.0% After Raising 2026 Revenue Outlook and Expanding Rare Disease Team
- Jan 14th, 2026 7:14 pm
ANI Pharmaceuticals Targets $1B+ 2026 Revenue as Rare Disease Pivot Accelerates, Cortrophin Leads Growth
- Jan 13th, 2026 10:02 pm
ANI Pharmaceuticals (ANIP) Stock Trades Down, Here Is Why
- Jan 13th, 2026 10:01 am
Stocks making big moves yesterday: OneMain, Nextpower, ANI Pharmaceuticals, Akamai Technologies, and Lemonade
- Jan 13th, 2026 6:00 am
Strength Seen in ANI (ANIP): Can Its 10.6% Jump Turn into More Strength?
- Jan 13th, 2026 2:21 am
Why ANI Pharmaceuticals (ANIP) Stock Is Trading Up Today
- Jan 12th, 2026 2:05 pm
ANI Pharmaceuticals Highlights Significant Growth in 2025, Provides 2026 Financial Guidance, and Outlines Strategic Priorities
- Jan 12th, 2026 4:50 am
1 of Wall Street’s Favorite Stock for Long-Term Investors and 2 That Underwhelm
- Jan 7th, 2026 9:42 pm
Is ANI Pharmaceuticals (ANIP) Price Justified After Updated 2025 Revenue Guidance?
- Jan 6th, 2026 3:18 pm
Scroll